August 11, 2014 / 11:30 AM / 3 years ago

Biodel's insulin drug found effective in trial

1 Min Read

Aug 11 (Reuters) - Biodel Inc said its experimental insulin formulation was found more effective than current therapies in controlling glucose after two meals, in a mid-stage trial.

The company's shares rose about 10 percent to $2.10 before the bell.

The study was testing the drug, BIOD-531, against Eli Lilly and Co's Humalog Mix 75/25 and Humulin R U-500 in patients with type 2 diabetes with moderate insulin resistance. (Reporting by Natalie Grover in Bangalore; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below